Morgan Stanley Upgrades Demant A/S (OTCMKTS:WILYY) to “Overweight”

Demant A/S (OTCMKTS:WILYY) was upgraded by stock analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research report issued on Tuesday.

Separately, Jefferies Financial Group upgraded shares of Demant A/S from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, March 18th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Strong Buy”.

Demant A/S Stock Performance

WILYY stock opened at $19.25 on Tuesday. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.36 and a quick ratio of 1.00. The firm has a 50 day simple moving average of $18.08 and a 200-day simple moving average of $16.35. Demant A/S has a twelve month low of $13.45 and a twelve month high of $21.30.

Demant A/S Company Profile

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.